Chesapeake Wealth Management
Source: SEC Form 13F · as of Mar 2026Chesapeake Wealth Management holds 10 biotech & pharma companies tracked by BioSniper, totaling $13.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$13.9M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 15,211 | $3.3M |
| LLYELI LILLY & Co | 3,142 | $2.9M |
| JNJJOHNSON & JOHNSON | 8,290 | $2.0M |
| MRKMerck & Co., Inc. | 14,755 | $1.8M |
| AMGNAMGEN INC | 3,334 | $1.2M |
| PMPhilip Morris International Inc | 4,448 | $735K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,527 | $684K |
| ABTABBOTT LABORATORIES | 4,855 | $498K |
| GILDGILEAD SCIENCES, INC. | 2,905 | $405K |
| BMYBRISTOL MYERS SQUIBB CO | 6,368 | $386K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.